BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of this AI platform, its scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers the Company’s in-house drug pipeline and supports successful collaborations with AstraZeneca, as well as leading research and charitable institutions.
View Top Employees from BenevolentAI| Website | http://benevolent.com |
| Revenue | $21 million |
| Funding | $115 million |
| Employees | 439 (439 on RocketReach) |
| Founded | 2013 |
| Phone | +44 20 3781 9360 |
| Technologies |
JavaScript,
HTML,
PHP
+24 more
(view full list)
|
| Category | Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Artificial Intelligence, Business Services, Science and Engineering, Drug Development, Nutraceutical, Health Care |
| Web Rank | 1 Million |
| Keywords | benevolentai, benevolent ai, benevolent tech, bioinformatics chemoinformatics startup, benevolentai janssen |
| SIC | 73, 737, 7372 |
| NAICS | 511210, 511, 5112, 51121, 51 |
Looking for a particular BenevolentAI employee's phone or email?
BenevolentAI Questions
The BenevolentAI annual revenue was $21 million in 2023.
Joanna Shields is the CEO of BenevolentAI.
439 people are employed at BenevolentAI.
The NAICS codes for BenevolentAI are [511210, 511, 5112, 51121, 51].
The SIC codes for BenevolentAI are [73, 737, 7372].
Top BenevolentAI Employees
-
2
-
35+
-
22
-
1
-
2
-
22
-
21
Related Companies
